Hogan v. Dow Chemical Co.

611 F. Supp. 1290, 2 Fed. R. Serv. 3d 460, 1985 U.S. Dist. LEXIS 19924
CourtDistrict Court, E.D. New York
DecidedMay 10, 1985
DocketMDL No. 381, CV-81-991
StatusPublished
Cited by2 cases

This text of 611 F. Supp. 1290 (Hogan v. Dow Chemical Co.) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hogan v. Dow Chemical Co., 611 F. Supp. 1290, 2 Fed. R. Serv. 3d 460, 1985 U.S. Dist. LEXIS 19924 (E.D.N.Y. 1985).

Opinion

MEMORANDUM, ORDER, and JUDGMENT

WEINSTEIN, Chief Judge:

Defendants, seven chemical companies who manufactured the herbicide Agent Orange, have moved to dismiss Dr. Gerald Hogan’s claims or in the alternative for summary judgment. Fed.R.Civ.P. 12(b), 56(b). They also seek dismissal for failure to comply with a discovery order. Fed.R. Civ.P. 37(b) and (d). Plaintiff opposes these motions and urges that diversity of citizenship did not exist at the time the suit was brought, making removal to federal court improper.

As indicated below, removal was proper. Plaintiff’s willful failure to comply with a discovery order and his failure to produce any evidence sufficient to show a causal connection between his injuries and exposure to Agent Orange require dismissal.

[1292]*1292I. FACTS

Hogan is a medical doctor who worked as a civilian contract physician for the United States Agency for International Development in a hospital in Vietnam in 1966. He was in Vietnam for no more than four months. During the first month he worked in a surgical and medical hospital located in the center of the City of Da Nang. He left the city only once during that month to visit a Special Forces camp 75 miles southwest of the city. The rest of his time in Vietnam he was a hospital patient.

Hogan claims that during that first month he was exposed to Agent Orange because of his physical contact with Vietnamese who had been exposed to Agent Orange and because dioxin was in Da Nang dust. He was diagnosed in Vietnam as having had an allergic reaction to penicillin or other allergens, an allergy which plaintiff was known to have had prior to his arrival in that country.

Upon his return from Vietnam, plaintiff was found to have allergic reactions to house dust, airborne molds, grasses, ragweed, cattle and dog hair, feathers, wool, silk, chocolate, and cola. He resumed his medical practice in cardiovascular surgery at Georgetown University in 1967, but left this position in 1971 due to declining health.

Currently, plaintiff claims that the following diseases and symptoms over the last 18 years result from his exposure to Agent Orange: elevated triglicerides; elevated SGOT; elevated total Bilirubin; elevated C4 (Bl-E-Globulin); immune deficiency; environmentally triggered vasculitis; hemi Parkinson’s disease; acne-like rash of the premalar area; weakness in extremities (possible peripheral neuropathy); hypoactive reflexes (possible peripheral neuropathy); chest pains; palpitations; and arrythmia.

The skin rashes, progressive vasculitis, and general deterioration of neurological functions were identified in 1975. The remaining illnesses were diagnosed in 1978 and subsequently.

II. PROCEDURAL HISTORY

On January 29, 1981, plaintiff sued the chemical companies in the Second Judicial District Court of Nevada. He charged that the defendants knew of the danger of contact with Agent Orange and failed to warn him.

In February 1981, defendants removed the suit to federal court based on diversity of citizenship. 28 U.S.C. §§ 1332 and 1441. Plaintiff did not challenge the removal. Once in federal court, the action was transferred to this court as part of the “Agent Orange” product liability litigation, MDL 381.

In August 1984, defendants moved to dismiss or, in the alternative, for summary judgment. Plaintiff did not reply and defendants obtained a default judgment. Plaintiff’s Rule 60 motion to reopen was granted and defendants renewed their motions.

III. LAW

A. Jurisdiction

Responding to defendants’ motion to dismiss or for summary judgment plaintiff suggests that no diversity exists. He states that since 1979 he has spent time in California, Hawaii, Mexico, Texas, Florida, and the Bahamas as well as in Nevada. It is to this jurisdictional issue that we first turn. McNutt v. General Motors Acceptance Corp., 298 U.S. 178, 182-84, 56 S.Ct. 780, 782-83, 80 L.Ed. 1135 (1936).

A statement of residence says little about domicile; it only declares where a party is living. John Birch Society v. National Broadcasting Co., 377 F.2d 194, 199 (2d Cir.1967). To change domicile, a person must take up residence in a different place with the intent of remaining there. Mas v. Perry, 489 F.2d 1396, 1399-1400 (5th Cir.), cert. denied, 419 U.S. 842, 95 S.Ct. 74, 42 L.Ed.2d 70 (1974).

Diversity at the time suit was brought provides sufficient predicate for jurisdiction. Stevens v. Nichols, 130 U.S. 230, 231, 9 S.Ct. 518, 519, 32 L.Ed. 914 (1889). Jurisdiction having once been vested, it is not divested by a later change of [1293]*1293domicile. Dery v. Wyer, 265 F.2d 804, 808 (2d Cir.1959).

Since plaintiff has never claimed a domicile other than Nevada, he is a citizen of Nevada. All the evidence supports that conclusion. In his Rule 60 motion plaintiff’s affidavit refers to Nevada as his “home state” when he brought suit. See Sun Printing and Publishing Association v. Edwards, 194 U.S. 377, 382, 24 S.Ct. 696, 697, 48 L.Ed. 1027 (1904). In their removal papers, defendants asserted that plaintiff was a citizen of Nevada and plaintiff failed to deny or to challenge removal; failure to object at that time can be taken as an admission. Wilson v. Republic Iron & Steel Co., 257 U.S. 92, 97-98, 42 S.Ct. 35, 37-38, 66 L.Ed. 144 (1921). Even now, his home appears to be in Nevada for that is where he repaired to give his deposition. The court has diversity jurisdiction.

B. Rule 37 Motion to Dismiss

Pursuant to the Magistrate’s Pretrial Order Number 36, defendants began what was to have been two days deposing plaintiff in his home in Las Vegas on March 21, 1985. The deposition began in the morning and lasted until noon. After lunch, plaintiff’s attorney informed defendants’ counsel that plaintiff was not able to continue with the deposition. Plaintiff claimed to be suffering from cardiac arrhythmia resulting from atmospheric conditions. There was no claim in the record of fatigue or mental confusion.

The following day, plaintiff refused to continue and suggested that he was considering discontinuing the suit. On March 27, the issue of the suspended deposition was raised with the Magistrate by telephone.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Agent Orange Product Liability Litigation
611 F. Supp. 1290 (E.D. New York, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
611 F. Supp. 1290, 2 Fed. R. Serv. 3d 460, 1985 U.S. Dist. LEXIS 19924, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hogan-v-dow-chemical-co-nyed-1985.